25 OCT 2017 Company Update

DABUR INDIA HOLD

FMCG Target Price: Rs 325

Going aggressive in hair oils

Dabur India has stepped up its aggression in the Indian hair oils CMP : Rs 318
Potential Upside : 2%
segment. Recent advertisements show Dabur offering its coconut light
hair oil at ~35% discount to similar offering by category leader Marico.
Its coconut hair oil is also at 20% discount to Marico’s offering. MARKET DATA
No. of Shares : 1,762 mn
As hair oil is in a structural slowdown, Dabur seeks to draw consumers
Free Float : 32%
in this high-loyalty category by disruptive pricing. While its bid to eat
Market Cap : Rs 560 bn
market share in the coconut oil category from Marico has met with 52-week High / Low : Rs 324 / Rs 259
limited success in the past, this time pricing discount is too steep and Avg. Daily vol. (6mth) : 1.6 mn shares
hence would be interesting to see consumer and Marico’s reaction. Bloomberg Code : DABUR IB Equity
Promoters Holding : 68%
Maintain HOLD with TP of Rs 325 on 35x forward P/E. We estimate
FII / DII : 18% / 8%
consolidated sales and EPS CAGR of 8% and 9% over FY17-19E with
OPM stable at 19.8%. Valuation at 36x FY19 P/E looks fair.

Fight for market share: Marico ate into share of Dabur’s forte, Amla hair oil, by offering its product at a discount.
Marico’s Nihar Shanti Amla hair oil (Amla hair oil offering) increased its value market share from 9% to 37% over FY10
to now at the cost of Dabur’s Amla oil whose share eroded from ~80% to ~55% over this period. In volume terms,
Marico (at ~40%) has overtaken Dabur. In May 2016, Dabur tried to cut into Marico’s forte, coconut hair oil, by offering
Dabur Anmol Gold at ~7-10% discount to Marico’s Parachute. However, Dabur was not much successful.
This time around, Dabur has priced its coconut light hair oil at 35% discount to Marico’s Parachute Coconut Hair
Oil Jasmine.

Our view: Hair oil category is in a structural slowdown. As per Nielsen, hair oil category volume has grown at sluggish
2.8% CAGR over FY10-16 with no volume growth over FY12-16. To drive growth, companies have not only stepped up
new product launches in existing categories but have also entered into new categories. Price disruption is a key tool to
switch consumers in this high-loyalty category. Around 20% discount in coconut oil and ~35% discount in coconut light
hair oil by Dabur is quite aggressive.

Financial summary (Consolidated) Key drivers

Y/E March FY16 FY17 FY18E FY19E (%) FY17 FY18E FY19E
Sales (Rs mn) 84,028 75,922 79,108 88,692 Dom sales growth (1.0) 7.2 11.0
Adj PAT (Rs mn) 12,500 12,768 13,642 15,329 Intl sales growth (4.9) (3.0) 15.0
Con. EPS* (Rs) - - 7.9 9.1 Gross margin (consol) 50.8 50.8 50.9
EPS (Rs) 7.1 7.2 7.7 8.7 EBITDA margin (consol) 19.9 19.6 19.8
Change YOY (%) 16.7 2.0 6.8 12.4
P/E (x) 44.7 43.8 41.0 36.5
Price performance
RoE (%) 33.2 28.3 26.0 25.1
120
Sensex Dabur India
RoCE (%) 33.9 30.4 29.3 29.9
110
EV/E (x) 35.4 35.4 34.0 29.6
100
DPS (Rs) 2.2 2.2 2.6 3.0
90
Source: *Consensus broker estimates, Company, Axis Capital
80
Oct-16 Jan-17 Apr-17 Jul-17 Oct-17
 25 OCT 2017 Company Update
DABUR INDIA
FMCG

Disruptive pricing to gain share in light hair oil

To gain share in light hair oil segment, Dabur India is looking to drive its Dabur
Anmol Coconut Oil Jasmine through disruptive pricing – at 35% discount to the
competition. The product launched in January 2017 is currently targeting states in
western India like Maharashtra, Gujarat and parts of Madhya Pradesh. The product
will be taken to northern India in the next phase and, then across India.
As the segment is less commoditized, Dabur will be maintaining disruptive product
pricing. Last year, when it launched price war in coconut oil through Dabur Anmol,
it gained 100-150 bps market share in the category (current share ~5% with Vatika
and Anmol brands).

Dabur’s aggressive price cuts in light hair oil (Oct-17)

Dabur highlighting its
product is available at a
discount of 35% to product
offering from category
leader Marico

Keep a note of product

formulation:
Product formulation for
Parachute Advanced
Jasmine comprises of
~80% LLP and 20%
coconut oil, while that for
Dabur Anmol Coconut Oil
Jasmine has 86% LLP and
10% coconut oil

Source: Media, Axis Capital

02
 25 OCT 2017 Company Update
DABUR INDIA
FMCG

Dabur cuts coconut oil price

In May 2016, Dabur offered Dabur Anmol Coconut oil at 7-10% discount to
Marico’s Parachute (the discounting has widened to ~20% since).

Dabur attacked Marico with price cuts in coconut hair oil (May-16)

Dabur highlights its

product is available at
7-10% discount to product
from category leader
Marico

Source: Media, Axis Capital

03
 25 OCT 2017 Company Update
DABUR INDIA
FMCG

Marico goes aggressive in Amla hair oil category

Marico cuts Amla hair oil price (Sep-14) English translation of the ad:

“ Nihar Shanti Amla is

better than Dabur Amla.
It also makes your hair
beautiful.
Nihar Shanti Amla has
500% higher Vitamin E than
Dabur Amla and costs 30%
lower.
So when do you plan to
change your oil? “

Pricing of key Amla oil

brands of 200ml pack:
 Dabur Amla – Rs 84
 Bajaj Brahmi Amla – Rs 84
 Shanti Amla − Rs 56 ^
^ (Standardized for 200ml based
on pricing of 175ml pack)

Source: Media, Axis Capital

Amla based hair oil pricing (Sep-17)

Offering Company Weight Price (Rs) Formulation
Dabur Amla Hair Oil Dabur 180 ml 84 Amla 58% LLP 40%
Dabur Amla Sarso Hair Oil Dabur 175 ml 47 Mustard and Amla extract 40%, LLP 58%
Nihar Shanti Amla Marico 175 ml 47 Amla Seed Oil 35% LLP 64%
Patanjali Kesh kanti Amla Hair Oil Patanjali 100 ml 40 NA
Bajaj Brahmi Amla Hair Oil Bajaj Corp 200 ml 84 LLP with Brahmi and Amla 61.5%, Vegetable oil 37.15%

Source: Company, Axis Capital

04
 25 OCT 2017 Company Update
DABUR INDIA
FMCG

Hair oil category

Hair oil category size (Rs mn)
Hair Care
Rs 196 bn

Coconut Oil Hair Oil

Rs 32.8 bn Rs 66.5 bn

Amla Based Oils Light Hair Oils VACNO Ayurvedic/ Herbal Cooling Hair Oils
45,065 Tn 33,989 Tn 29,292 Tn 7,730 Tn 19,013 Tn (1%)
Rs 15.7 bn Rs 16.9 bn Rs 11.2 bn Rs 7.4 bn Rs 9.6 bn

Source: Bloomberg, Axis Capital

Valuations
1-year fwd. PE on consensus EPS

PE (x) 10 yr median
40
35
30
25
20
15
10
Oct-06

Oct-07

Oct-08

Oct-11

Oct-12

Oct-15

Oct-16

Oct-17
Oct-09

Oct-10

Oct-13

Oct-14

Source: Bloomberg, Axis Capital

05
 25 OCT 2017 Company Update
DABUR INDIA
FMCG
Financial summary (Consolidated)
Profit & loss (Rs mn) Cash flow (Rs mn)
Y/E March FY16 FY17 FY18E FY19E Y/E March FY16 FY17 FY18E FY19E
Net sales 84,028 75,922 79,108 88,692 Profit before tax 15,546 16,103 17,149 19,345
Other operating income 181 214 134 149 Depreciation & Amortisation 1,338 1,429 1,620 1,709
Total operating income 84,209 76,136 79,242 88,840 Chg in working capital 1,078 156 (1,072) (551)
Cost of goods sold (37,976) (37,554) (39,049) (43,676) Cash flow from operations 13,134 10,513 10,631 12,935
Gross profit 46,233 38,582 40,193 45,164 Capital expenditure (2,338) (598) (3,079) (2,000)
Gross margin (%) 55.0 50.8 50.8 50.9 Cash flow from investing (7,869) (5,161) 3,330 41
Total operating expenses (31,008) (23,493) (24,663) (27,561) Equity raised/ (repaid) 3 2 - -
EBITDA 15,225 15,090 15,529 17,603 Debt raised/ (repaid) (1,566) 1,073 (6,465) -
EBITDA margin (%) 18.1 19.9 19.6 19.8 Dividend paid (4,764) (4,770) (5,516) (6,364)
Depreciation (1,338) (1,429) (1,620) (1,709) Cash flow from financing (5,821) (4,507) (12,018) (6,358)
EBIT 13,888 13,661 13,910 15,894 Net chg in cash (556) 844 1,943 6,619
Net interest (480) (540) (354) (139)
Other income 2,138 2,982 3,594 3,589 Key ratios
Profit before tax 15,546 16,103 17,149 19,345 Y/E March FY16 FY17 FY18E FY19E
Total taxation (3,018) (3,303) (3,473) (3,979) OPERATIONAL
Tax rate (%) 19.4 20.5 20.2 20.6 FDEPS (Rs) 7.1 7.2 7.7 8.7
Profit after tax 12,528 12,800 13,677 15,367 CEPS (Rs) 7.9 8.1 8.7 9.7
Minorities (27) (31) (34) (38) DPS (Rs) 2.2 2.2 2.6 3.0
Profit/ Loss associate co(s) - - - - Dividend payout ratio (%) 31.6 31.0 33.6 34.5
Adjusted net profit 12,500 12,768 13,642 15,329 GROWTH
Adj. PAT margin (%) 14.9 16.8 17.2 17.3 Net sales (%) 8.1 (9.6) 4.2 12.1
Net non-recurring items 27 1 - - EBITDA (%) 15.3 (0.9) 2.9 13.4
Reported net profit 12,527 12,770 13,642 15,329 Adj net profit (%) 16.9 2.1 6.8 12.4
FDEPS (%) 16.7 2.0 6.8 12.4
Balance sheet (Rs mn) PERFORMANCE
Y/E March FY16 FY17 FY18E FY19E RoE (%) 33.2 28.3 26.0 25.1
Paid-up capital 1,759 1,762 1,762 1,762 RoCE (%) 33.9 30.4 29.3 29.9
Reserves & surplus 39,947 46,712 54,882 63,891 EFFICIENCY
Net worth 41,706 48,474 56,643 65,652 Asset turnover (x) 3.8 3.5 3.4 3.5
Borrowing 7,922 9,115 2,650 2,650 Sales/ total assets (x) 1.3 1.0 1.0 1.0
Other non-current liabilities 882 1,080 983 983 Working capital/ sales (x) - 0.1 - 0.1
Total liabilities 50,727 58,917 60,576 69,585 Receivable days 35.1 31.3 35.8 37.2
Gross fixed assets 25,538 28,427 31,727 33,727 Inventory days 58.0 66.2 71.9 74.0
Less: Depreciation (8,258) (8,843) (10,463) (12,171) Payable days 70.4 77.9 80.6 82.0
Net fixed assets 17,280 19,584 21,264 21,556 FINANCIAL STABILITY
Add: Capital WIP 448 421 200 200 Total debt/ equity (x) 0.2 0.2 0.1 -
Total fixed assets 17,728 20,005 21,464 21,756 Net debt/ equity (x) (0.5) (0.6) (0.6) (0.6)
Total Investment 26,433 32,525 29,757 30,757 Current ratio (x) 1.4 1.3 1.5 1.8
Inventory 10,965 11,067 12,553 14,441 Interest cover (x) 28.9 25.3 39.3 114.8
Debtors 8,092 6,504 7,755 9,031 VALUATION
Cash & bank 2,198 3,048 4,992 11,610 PE (x) 44.7 43.8 41.0 36.5
Loans & advances 3,586 3,820 3,772 4,320 EV/ EBITDA (x) 35.4 35.4 34.0 29.6
Current liabilities 18,596 18,393 20,093 22,744 EV/ Net sales (x) 6.4 7.0 6.7 5.9
Net current assets 6,566 6,387 9,355 17,072 PB (x) 13.4 11.5 9.9 8.5
Other non-current assets - - - - Dividend yield (%) 0.7 0.7 0.8 0.9
Total assets 50,727 58,917 60,576 69,585 Free cash flow yield (%) - - - -
Source: Company, Axis Capital Source: Company, Axis Capital

06
 25 OCT 2017 Company Update
DABUR INDIA
FMCG

Disclosures:

The following Disclosures are being made in compliance with the SEBI Research Analyst Regulations 2014 (herein after referred to as the Regulations).

1. Axis Securities Ltd. (ASL) is a SEBI Registered Research Analyst having registration no. INH000000297. ASL, the Research Entity (RE) as defined in the
Regulations, is engaged in the business of providing Stock broking services, Depository participant services & distribution of various financial
products. ASL is a subsidiary company of Axis Bank Ltd. Axis Bank Ltd. is a listed public company and one of India’s largest private sector bank and
has its various subsidiaries engaged in businesses of Asset management, NBFC, Merchant Banking, Trusteeship, Venture Capital, Stock Broking, the
details in respect of which are available on www.axisbank.com.
2. ASL is registered with the Securities & Exchange Board of India (SEBI) for its stock broking & Depository participant business activities and with the
Association of Mutual Funds of India (AMFI) for distribution of financial products and also registered with IRDA as a corporate agent for insurance
business activity.
3. ASL has no material adverse disciplinary history as on the date of publication of this report.
4. I/We, authors (Research team) and the name/s subscribed to this report, hereby certify that all of the views expressed in this research report accurately
reflect my/our views about the subject issuer(s) or securities. I/We also certify that no part of my/our compensation was, is, or will be directly or
indirectly related to the specific recommendation(s) or view(s) in this report. I/we or my/our relative or ASL does not have any financial interest in the
subject company. Also I/we or my/our relative or ASL or its Associates may have beneficial ownership of 1% or more in the subject company at the
end of the month immediately preceding the date of publication of the Research Report. Since associates of ASL are engaged in various financial
service businesses, they might have financial interests or beneficial ownership in various companies including the subject company/companies
mentioned in this report. I/we or my/our relative or ASL or its associates do not have any material conflict of interest. I/we have not served as director,
officer or employee in the subject company.

Research Team

Sr. No Name Designation E-mail

1 Hiren Trivedi Research Associate hiren.trivedi@axissecurities.in
2 Kiran Gawle Associate kiran.gawle@axissecurities.in

5. ASL or its associates has not received any compensation from the subject company in the past twelve months. ASL or its Research Analysts has not
been engaged in market making activity for the subject company.

6. In the last 12-month period ending on the last day of the month immediately preceding the date of publication of this research report, ASL or any of
its associates may have:

i. Received compensation for investment banking, merchant banking or stock broking services or for any other services from the subject
company of this research report and / or;
ii. Managed or co-managed public offering of the securities from the subject company of this research report and / or;
iii. Received compensation for products or services other than investment banking, merchant banking or stock broking services from the subject
company of this research report;

ASL or any of its associates have not received compensation or other benefits from the subject company of this research report or any other third-party
in connection with this report

Term& Conditions:

This report has been prepared by ASL and is meant for sole use by the recipient and not for circulation. The report and information contained herein is
strictly confidential and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or
reproduced in any form, without prior written consent of ASL. The report is based on the facts, figures and information that are considered true, correct,
reliable and accurate. The intent of this report is not recommendatory in nature. The information is obtained from publicly available media or other
sources believed to be reliable. Such information has not been independently verified and no guaranty, representation of warranty, express or implied, is
made as to its accuracy, completeness or correctness. All such information and opinions are subject to change without notice. The report is prepared
solely for informational purpose and does not constitute an offer document or solicitation of offer to buy or sell or subscribe for securities or other
financial instruments for the clients. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same
time. ASL will not treat recipients as customers by virtue of their receiving this report.

07
 25 OCT 2017 Company Update
DABUR INDIA
FMCG

DEFINITION OF RATINGS
Ratings Expected absolute returns over 12-18 months
BUY More than 10%
HOLD Between 10% and -10%
SELL Less than -10%
Disclaimer:

Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable or appropriate
to the recipient’s specific circumstances. The securities and strategies discussed and opinions expressed, if any, in this report may not be suitable for all
investors, who must make their own investment decisions, based on their own investment objectives, financial positions and needs of specific recipient.

This report may not be taken in substitution for the exercise of independent judgment by any recipient. Each recipient of this report should make such
investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this report
(including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. Certain
transactions, including those involving futures, options and other derivatives as well as non-investment grade securities involve substantial risk and are not
suitable for all investors. ASL, its directors, analysts or employees do not take any responsibility, financial or otherwise, of the losses or the damages
sustained due to the investments made or any action taken on basis of this report, including but not restricted to, fluctuation in the prices of shares and
bonds, changes in the currency rates, diminution in the NAVs, reduction in the dividend or income, etc. Past performance is not necessarily a guide to
future performance. Investors are advise necessarily a guide to future performance. Investors are advised to see Risk Disclosure Document to understand
the risks associated before investing in the securities markets. Actual results may differ materially from those set forth in projections. Forward-looking
statements are not predictions and may be subject to change without notice.

ASL and its affiliated companies, their directors and employees may; (a) from time to time, have long or short position(s) in, and buy or sell the securities of
the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities or earn brokerage or other compensation or act as a
market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or investment banker, lender/borrower to such
company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions. Each of
these entities functions as a separate, distinct and independent of each other. The recipient should take this into account before interpreting this document.

ASL and / or its affiliates do and seek to do business including investment banking with companies covered in its research reports. As a result, the
recipients of this report should be aware that ASL may have a potential conflict of interest that may affect the objectivity of this report. Compensation of
Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. ASL may have issued other reports
that are inconsistent with and reach different conclusion from the information presented in this report.

Neither this report nor any copy of it may be taken or transmitted into the United State (to U.S. Persons), Canada, or Japan or distributed, directly or
indirectly, in the United States or Canada or distributed or redistributed in Japan or to any resident thereof. If this report is inadvertently sent or has
reached any individual in such country, especially, USA, the same may be ignored and brought to the attention of the sender. This report is not directed or
intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction,
where such distribution, publication, availability or use would be contrary to law, regulation or which would subject ASL to any registration or licensing
requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of
investors.

The Disclosures of Interest Statement incorporated in this document is provided solely to enhance the transparency and should not be treated as
endorsement of the views expressed in the report. The Company reserves the right to make modifications and alternations to this document as may be
required from time to time without any prior notice. The views expressed are those of the analyst(s) and the Company may or may not subscribe to all the
views expressed therein.

Copyright in this document vests with Axis Securities Limited.

Axis Securities Limited, Corporate office: Unit No. 2, Phoenix Market City, 15, LBS Road, Near Kamani Junction, Kurla (west), Mumbai-400070, Tel No. –
18002100808/022-61480808, Regd. off.- Axis House, 8th Floor, Wadia International Centre, PandurangBudhkarMarg, Worli, Mumbai – 400 025. Compliance
Officer: AnandShaha, Email: compliance.officer@axisdirect.in, Tel No: 022-42671582. SEBI-Portfolio Manager Reg. No. INP000000654

08